fluorouracil has been researched along with bleomycetin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Alferov, VS; Khlebnov, AV | 1 |
Batov, SV; Zharkov, SA | 1 |
Cai, HY | 1 |
Chen, ZM; Jiang, Y; Qiu, XH; Yang, YX; Zhang, SQ | 1 |
Cai, BL; Fu, SM; Guan, SM; Shen, LL; Wu, JZ; Xu, XF; Zhang, J | 1 |
Gong, L; Liu, H; Lou, JY; Peng, ZL; Wang, P; Zhang, JW | 1 |
Gu, Y; He, Z; Peng, B; Yi, S; Zheng, G | 1 |
Sun, Y; Wu, J; Ye, G; Zhao, Y; Zhou, L | 1 |
2 trial(s) available for fluorouracil and bleomycetin
Article | Year |
---|---|
[Elaboration of the combination of antitumor preparations bleomycetin + 5-fluorouracil + cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Fluorouracil; Humans; Neoplasms; Remission Induction; Time Factors | 1988 |
[Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leucovorin; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Proportional Hazards Models; Remission Induction; Survival Rate | 2006 |
6 other study(ies) available for fluorouracil and bleomycetin
Article | Year |
---|---|
[Use of 5-fluorouracil, bleomycetin and platidiam in combined treatment of localized cancer of the larynx].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged | 1991 |
[Establishment and application of transplantable models of human esophageal carcinoma in nude mice].
Topics: Animals; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Models, Animal; Esophageal Neoplasms; Fluorouracil; Hematoporphyrin Derivative; Hematoporphyrin Photoradiation; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation | 1993 |
Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bleomycin; Blotting, Western; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluorescent Antibody Technique, Indirect; Fluorouracil; Humans; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Salivary Gland Neoplasms | 2011 |
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Hysterectomy; Ifosfamide; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2012 |
Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).
Topics: Animals; Antibiotics, Antineoplastic; Antibody Specificity; Bleomycin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Fluorouracil; Humans; Hydrophobic and Hydrophilic Interactions; Immune Sera; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Protein Binding; Proteins; Recombinant Fusion Proteins | 2012 |
Effects of CD133 expression on chemotherapy and drug sensitivity of adenoid cystic carcinoma.
Topics: AC133 Antigen; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bleomycin; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Therapy; Fluorouracil; Humans; Multidrug Resistance-Associated Proteins; RNA, Messenger; RNA, Small Interfering | 2022 |